[1] |
Stall B, Zach L, NingH, et al.
Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas[J]. Radiat OncolRadiat Oncol, 2010, 5: 5-.
doi: 10.1186/1748-717X-5-5
|
[2] |
Yamasaki F, Sugiyama K, Ohtaki M, et al.
Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging[J]. Eur J RadiolEur J Radiol, 2010, 73(3): 532-537.
doi: 10.1016/j.ejrad.2009.01.013
|
[3] |
Saconn PA, Shaw EG, Chan MD, et al.
Useof3.0-TMRIforstereotactic radiosurgery planning for treatment of brain metastases: a singleinstitution retrospective review[J]. Int J Radiat Oncol Biol PhysInt J Radiat Oncol Biol Phys, 2010, 78(4): 1142-1146.
|
[4] |
Heiland S, Wick W, Bendszus M.
Perfusion magnetic resonance imaging for parametric response maps in tumors: is it really that easy?[J]. J Clin OncolJ Clin Oncol, 2010, 28(29): e591-.
doi: 10.1200/JCO.2010.30.3586
|
[5] |
Prabhakar R, Haresh KP, Ganesh T, et al.
Comparison of computed tomography and magnetic resonance based target volume in brain tumors[J]. J Cancer Res TherJ Cancer Res Ther, 2007, 3(2): 121-123.
doi: 10.4103/0973-1482.34694
|
[6] |
李丹明, 朱锡旭, 武新虎.
不同MRI与CT图像融合对脑胶质瘤术后放疗靶区勾画的稳定性研究[J]. 中国癌症杂志中国癌症杂志, 2008, 18(1): 46-50.
doi: 10.3969/j.issn.1007-3639.2008.01.011
|
[7] |
Ulin K, Urie MM, Cherlow JM.
Results of a multi-institutional bench-mark test for cranial CT/MR image registration[J]. Int J Radiat Oncol Biol PhysInt J Radiat Oncol Biol Phys, 2010, 77(5): 1584-1589.
doi: 10.1016/j.ijrobp.2009.10.017
|
[8] |
Farace P, Giri M, Meliadò G, et al.
Clinical target volume delineation in gliblastomas: pre-operative versus post-operative/preradiotherapy MRI[J]. Br J RadiolBr J Radiol, 2011, 84(999): 271-278.
doi: 10.1259/bjr/10315979
|
[9] |
Pantelis E, Papadakis N, Verigos K, et al.
Integration of functional MRI and white matter tractography in stereotactic radiosurgery clinicalpractice[J]. Int J Radiat Oncol Biol PhysInt J Radiat Oncol Biol Phys, 2010, 78(1): 257-267.
doi: 10.1016/j.ijrobp.2009.10.064
|
[10] |
Jonsson JH, Karlsson MG, Karlsson M, et al.
Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions[J]. Radiat OncolRadiat Oncol, 2010, 5: 62-.
doi: 10.1186/1748-717X-5-62
|
[11] |
Prabhakar R, Julka PK, Ganesh T, et al.
Feasibility of using MRI alone for 3D radiation treatment planning in brain tumors[J]. Jpn J Clin OncolJpn J Clin Oncol, 2007, 37(6): 405-411.
doi: 10.1093/jjco/hym050
|
[12] |
孟庆勇, 余永强.
放射性脑损伤的MRI研究进展[J]. 国际医学放射学杂志国际医学放射学杂志, 2008, 31(5): 341-344.
doi: 10.3784/j.issn.1674-1897.2008.05.006
|
[13] |
Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, et al.
Differentiation between brain tumor recurrence and radiation in jury using perfusion, diffusion-weighted imaging and MR spectroscopy[J]. Folia NeuropatholFolia Neuropathol, 2010, 48(2): 81-92.
|
[14] |
Pra t R, Galeano I, Lucas A, et al.
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2(-18F)fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas[J]. J Clin NeurosciJ Clin Neurosci, 2010, 17(1): 50-53.
doi: 10.1016/j.jocn.2009.02.035
|
[15] |
Mitsuya K, Nakasu Y, Horiguchi S, et al.
Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery[J]. JNeurooncolJNeurooncol, 2010, 99(1): 81-88.
doi: 10.1007/s11060-009-0106-z
|
[16] |
Zeng QS, Li CF, Zhang K, et al.
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury[J]. J NeurooncolJ Neurooncol, 2007, 84(1): 63-69.
doi: 10.1007/s11060-007-9341-3
|
[17] |
Sundgren PC.
MR spectroscopy in radiation injury[J]. AJNR Am J NeuroradiolAJNR Am J Neuroradiol, 2009, 30(8): 1469-1476.
doi: 10.3174/ajnr.A1580
|